Efficacy and safety of Apatinib in stage IV sarcomas: experience of a major sarcoma center in China

Abstract

CApatinib treatment in this exploratory study exhibited objective efficacy and manageable toxicity in stage IV sarcoma patients who failed in chemotherapy. This result supports future random controlled trial to further define Apatinib activity in stage IV sarcomas.